Jyotishbhai Patel: Why India Needs Universal Newborn Screening for Sickle Cell and Thalassemia
Jyotishbhai Patel, Chief Executive Officer at Sickle Cell Treatment and Research Centre, shared a post on LinkedIn:
“Sickle cell and Thalassemia are common in India.
Both are genetically inherited and need early diagnosis and care by team of experts health care provider.
In USA and even in Africa new born screening for Sickle cell and Thalassemia diagnosis exist, sadly India is lacking such initiative.
Every family needs to be screened for both to curtail rise in prevalence and disease burden.
With help of HPLC this can be done easily.
I would request concern Ministry in India and intervene.
Late diagnosis kills many such sufferer at early age.
Here is a child with Sickle cell disease(SS) diagnosed at four month age at dedicated outreach clinic: Sickle Cell Treatment Centre, Bodeli Chhotaudepur Gujarat India.”
Stay updated with Hemostasis Today.
-
Sep 12, 2026, 04:04Oliver Schlager: New ESC and ESVM Clinical Consensus on Lipid-Lowering Therapy in VTE
-
Sep 12, 2026, 03:54Toby Richards: Representing IronLife at Parliament on Anaemia and Iron Deficiency
-
Sep 12, 2026, 03:50Saleh Shamse Basha: When ‘Low Protein S’ Isn’t Necessarily Low
-
Sep 11, 2026, 17:41Khaled Musallam: Earlier Recognition, Better Outcomes in NTDT
-
Sep 11, 2026, 17:29Reyhan Kose Cobanoglu: APS ACTION Registry Study Published in Lupus
-
Sep 11, 2026, 17:14Obi Light Ogbonnia: From Kenya to Global Sickle Cell Advocacy
-
Sep 11, 2026, 17:01EAHAD 2027 Marks 20 Years
-
Sep 11, 2026, 16:54Denise Braendgaard: Reimagining Health Systems Through Collective Action
-
Sep 11, 2026, 16:47Jehad Khamaysa: Budd-Chiari Syndrome as the Initial Presentation of Behçet’s Disease in a 16-Year-Old